MANUFACTURING OF HYBRIDOMAS-PRODUCERS OF MONOCLONAL ANTIBODIES TO BRUCELLOSIS AGENT ANTIGENS
https://doi.org/10.21055/0370-1069-2017-2-67-71
Abstract
Objective of study is to prepare hybridomas-producers of monoclonal antibodies to brucellosis agent antigens. Materials and methods. B. abortus, B. melitensis, B. suis strains from the State collection of microorganisms of the 48th Central Research Institute Affiliated Branch and BALB/c mice. Hybridization was performed as described by G.Kohler and C.Milstein in modification by Fazekas De St. and Scheidegger D. The study of specific activity of immune sera, hybridoma supernatants, ascites fluid, and monoclonal antibody preparations was performed using ELISA. Results and conclusions. Obtained and characterized have been hybridomas-producers of monoclonal antibodies to specific antigens of brucellosis agent. They are active and stable antibody producers in the repeated passaging both, in vitro and in vivo. Obtained have also been the ascites fluid and preparations of monoclonal antibodies of brucellosis agent. Carried out has been substantiated selection of antibodies which could provide for the most sensitive ELISA. It is established that the monoclonal antibodies produced by hybridomas 232B6H7, 232G12F7, 233B2C5 in combination with brucellosis rabbit immunoglobulins allow for the identification of microbial cells of type strains of various Brucella species in concentrations ranging from 0,25·106 mc·sm–3 up to 1,0·106 mc·sm–3 and gave negative results with cultures of heterologous microorganisms in the contents of 1,0·108 mc·sm–3. Hybridomas-producers of monoclonal antibodies are planned to be used for the construction and manufacturing of immunodetection test-systems.
About the Authors
G. V. KuklinaRussian Federation
G. D. Elagin
Russian Federation
O. O. Fomenkov
Russian Federation
D. V. Pechenkin
Russian Federation
A. V. Eremkin
Russian Federation
A. A. Kytmanov
Russian Federation
References
1. Zheludkov M.M., Tsirel’son L.E., Gorshenko V.V., KulakovYu.K. [Epidemic manifestations of contemporary brucellosis in the Russian Federation]. Epidemiol. i Vaktsinoprofilakt. 2009; 10:38–40.
2. Lyamkin G.I., Manin E.A., Golovneva S.I., Tikhenko N.I., Kulichenko A.N. [Epidemiological situation on brucellosis in the Russian Federation in 2012 and the forecast for 2013]. Probl. Osobo Opasn. Infek. 2013; 1(115):21–4.
3. Lyamkin G.I., Khudoleev A.A., Khachaturova A.N., Kulichenko A.N. [Review of epidemiological situation on brucellosis in the Russian Federation in 2014 and the forecast for 2015]. Probl. Osobo Opasn. Infek. 2015; 2:22–4.
4. Onishchenko G.G., Kutyrev V.V., editors. [Laboratory Diagnostics of Dangerous Infectious Diseases. Practice Guidelines]. M.: CJSC “Shiko”; 2013. 560 p.
5. Fel’dsherova A.A., El’gort D.A., Konopleva M.V., Hats Yu.S., Tret’yakov O.Yu., Kulakov Yu.K., Tolmacheva T.A., Zheludkov M.M., Suslov A.P. [Highly sensitive immuno-enzyme test system based on monoclonal antibodies to detect brucella antigens]. Zh. Mikrobiol. Epidemiol. Infek. Bol. 2007; 1:52–7.
6. Tsirel’son L.E., Zheludkov M.M. [Brucellosis in Russia: occupational diseases and labor forecast]. Epidemiol. Infek. Bol. 2011; 5:43–7.
7. Fazekas De St., Groth S., Scheidegger D. Production of monoclonal antibodies: strategy and tactics. J. Immunol. Meth. 1980; 35:1–21.
8. Gerbier G., Garin-Bastuji B., Pouillot R. False-positive serological reactions in bovine brecellosis: evidence of the role of Yersinia enterocolitica O:9. Vet. Res. 1997; 28:375–83.
9. Kohler G., Milstein C. Continuous culture of fused cells secreting antibody of predefined specificity. Nature. 1975; 256(5517):495–97.
10. Nakane P.K., Kawaoi A.J. Peroxidase-labeled antibody. A new method of conjugation. Histochem. Cytochem. 1974; 22(12):1084–91.
Review
For citations:
Kuklina G.V., Elagin G.D., Fomenkov O.O., Pechenkin D.V., Eremkin A.V., Kytmanov A.A. MANUFACTURING OF HYBRIDOMAS-PRODUCERS OF MONOCLONAL ANTIBODIES TO BRUCELLOSIS AGENT ANTIGENS. Problems of Particularly Dangerous Infections. 2017;(2):67-71. (In Russ.) https://doi.org/10.21055/0370-1069-2017-2-67-71